Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
grade D 46.79 0.00% 0.00
NVO closed unchanged on Friday, May 17, 2019, on 81 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NVO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%

Older signals for NVO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Obesity Hormones Insulin Peptide Hormones Biopharmaceuticals Diabetes Care Glucagon Like Peptide 1 Anti Diabetic Drugs Hormone Therapy
Is NVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.83
52 Week Low 41.23
Average Volume 1,267,393
200-Day Moving Average 47.5002
50-Day Moving Average 49.7914
20-Day Moving Average 48.082
10-Day Moving Average 47.521
Average True Range 0.7221
ADX 29.55
+DI 14.0152
-DI 32.3909
Chandelier Exit (Long, 3 ATRs ) 47.4437
Chandelier Exit (Short, 3 ATRs ) 48.6363
Upper Bollinger Band 49.705
Lower Bollinger Band 46.459
Percent B (%b) 0.1
BandWidth 6.750967
MACD Line -0.7739
MACD Signal Line -0.6745
MACD Histogram -0.0995
Fundamentals Value
Market Cap 116.05 Billion
Num Shares 2.48 Billion
EPS 2.49
Price-to-Earnings (P/E) Ratio 18.79
Price-to-Sales 6.57
Price-to-Book 15.49
PEG Ratio 2.42
Dividend 0.95
Dividend Yield 2.03%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.33
Resistance 3 (R3) 47.38 47.24 47.24
Resistance 2 (R2) 47.24 47.11 47.22 47.21
Resistance 1 (R1) 47.02 47.02 46.95 46.97 47.18
Pivot Point 46.88 46.88 46.85 46.86 46.88
Support 1 (S1) 46.66 46.75 46.59 46.61 46.40
Support 2 (S2) 46.52 46.66 46.50 46.37
Support 3 (S3) 46.30 46.52 46.34
Support 4 (S4) 46.25